Gout is a common form of arthritis characterized by sudden, severe attacks of pain and inflammation in the joints, often in the big toe. It is caused by high levels of uric acid in the blood that form needle-like crystals in the joints. Risk factors include age, genetics, diet high in purines, obesity, kidney problems, and certain medications. Symptoms include intense joint pain, swelling, redness, and limited range of motion. Diagnosis involves testing joint fluid or blood for uric acid crystals. Treatment focuses on medications to relieve pain and prevent further attacks and complications by reducing uric acid levels.
Drugs for Gout ( Acute and Chronic gout)ANUSHA SHAJI
The current presentation include the pharmacotherapy of drugs for acute and chronic gout. Details include definition, classification of drugs, mechanism, pharmacokinetics, adverse effects, uses and contraindications.
Drugs for Gout ( Acute and Chronic gout)ANUSHA SHAJI
The current presentation include the pharmacotherapy of drugs for acute and chronic gout. Details include definition, classification of drugs, mechanism, pharmacokinetics, adverse effects, uses and contraindications.
Gout is a form of inflammatory arthritis that results from an excess of uric acid in the blood.
Uric acid is a chemical that is created in the body when it digests and breaks down certain substances in food called purines. Gout is genetically inherited and affects men more than women by a ratio of about 3 to 1.
The key symptom is painful attacks in the joints – often, appearing first in the big toe. Other joints that may be affected include the ankle, foot, knees and, in severe cases, the wrists, elbows and fingers. People with gout may also experience kidney stones and damage to their kidneys.
What causes gout?
Gout is caused by disordered metabolism of purines. In people with gout, an excess of purines causes uric acid to crystallize in the joints, causing inflammation and pain.
You get purines mostly from food, and they are essential for the body to work properly. Excess purines are normally eliminated in the urine. But sometimes, an excess can lead high levels of urate (a breakdown product of purines) in the blood. This is called hyperuricemia, and it can leave needle-like urate crystals inside your joints.
A similar condition, known as pseudogout has similar symptoms. In both conditions, white blood cells surround chemical crystals, which leads to inflammation. In pseudogout, the associated crystals are formed from calcium pyrophosphate dihydrate, rather than from uric acid, as in gout. Pseudogout requires different treatment.
Gout risk factors
Men get gout more than women by about three to one. Having one or more of the following conditions puts someone at a higher risk for gout.
kidney dysfunction
heart disease
obesity
high cholesterol
high triglycerides
diabetes
How is gout diagnosed?
Diagnosis of gout usually involves:
a physical exam of the joints
X-rays of affected joints
extraction synovial fluid of an affected joint to look for crystals of uric acid
Gout causes severe pain, swelling and stiffness in the joints. This article details the symptoms, causes and treatment options along with the ICD-10 codes.
Gout is an inflammatory condition of the arthritis-type that results from deposition of monosodium urate crystals in joint spaces or surrounding tissues, leading to an inflammatory reaction that causes intense pain, erythema, and joint swelling.
It is associated with hyperuricemia, defined as a Serum Uric Acid (SUA) level of 6.8 mg/dL (404 μmol/L) or greater, but not all patients with hyperuricemia demonstrate symptoms.
Inflammation of arthritis type
Hyperuricemia
Metatarsophalangeal joint
Pharmacotherapeutics
M.Pharmacy
Pharmacy practice
Unit 05
What are the signs of gout? Gout is a painful condition, often affecting the toes, but it can affect many other joints as well. If left alone it can get worse, turn into a chronic problem and even cause permanent damage
Immunosuppressants are drugs which inhibit cellular/humoral or both types of immune responses and have their major use in organ transplantation and autoimmune diseases.
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...Levi Shapiro
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
Embracing GenAI - A Strategic ImperativePeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdfTechSoup
In this webinar you will learn how your organization can access TechSoup's wide variety of product discount and donation programs. From hardware to software, we'll give you a tour of the tools available to help your nonprofit with productivity, collaboration, financial management, donor tracking, security, and more.
Model Attribute Check Company Auto PropertyCeline George
In Odoo, the multi-company feature allows you to manage multiple companies within a single Odoo database instance. Each company can have its own configurations while still sharing common resources such as products, customers, and suppliers.
Instructions for Submissions thorugh G- Classroom.pptxJheel Barad
This presentation provides a briefing on how to upload submissions and documents in Google Classroom. It was prepared as part of an orientation for new Sainik School in-service teacher trainees. As a training officer, my goal is to ensure that you are comfortable and proficient with this essential tool for managing assignments and fostering student engagement.
How to Make a Field invisible in Odoo 17Celine George
It is possible to hide or invisible some fields in odoo. Commonly using “invisible” attribute in the field definition to invisible the fields. This slide will show how to make a field invisible in odoo 17.
Biological screening of herbal drugs: Introduction and Need for
Phyto-Pharmacological Screening, New Strategies for evaluating
Natural Products, In vitro evaluation techniques for Antioxidants, Antimicrobial and Anticancer drugs. In vivo evaluation techniques
for Anti-inflammatory, Antiulcer, Anticancer, Wound healing, Antidiabetic, Hepatoprotective, Cardio protective, Diuretics and
Antifertility, Toxicity studies as per OECD guidelines
Macroeconomics- Movie Location
This will be used as part of your Personal Professional Portfolio once graded.
Objective:
Prepare a presentation or a paper using research, basic comparative analysis, data organization and application of economic information. You will make an informed assessment of an economic climate outside of the United States to accomplish an entertainment industry objective.
1. GOUT
Gout is a common and complex form of arthritis that can affect anyone. It's characterized by sudden,
severe attacks of pain, swelling, redness and tenderness in the joints, often the joint at the base of the
big toe.
Causes
Gout is caused initially by an excess of uric acid in the blood, or hyperuricemia.
Uric acid is produced in the body during the breakdown of purines – chemical compounds that
are found in high amounts in certain foods such as meat, poultry, and seafood.
Normally, uric acid is dissolved in the blood and is excreted from the body in urine via the
kidneys.
If too much uric acid is produced, or not enough is excreted, it can build up and form needle-like
crystals that trigger inflammation and pain in the joints and surrounding tissue.
Pathogenesis
An elevated serum urate level, together with local factors, can result in the deposition of urate
crystals into the joints. Once crystals are deposited into a joint, they can be released into the
joint space and initiate an inflammatory cascade causing acute gouty arthritis.
2. Signs and symptoms
Signs and symptoms of gout almost always occur suddenly, and often at night. They include:
Intense joint pain. Gout usually affects the large joint of big toe, but it can occur in any joint.
Other commonly affected joints include the ankles, knees, elbows, wrists and fingers. The pain is
likely to be most severe within the first four to 12 hours after it begins.
Lingering discomfort. After the most severe pain subsides, some joint discomfort may last from
a few days to a few weeks. Later attacks are likely to last longer and affect more joints.
Inflammation and redness. The affected joint or joints become swollen, tender, warm and red.
Limited range of motion. As gout progresses, you may not be able to move joints normally.
Risk factors
There are a number of factors that can increase the likelihood of hyperuricemia, and therefore gout:
3. Age and gender: Men produce more uric acid than women, though women’s levels of uric acid approach
those of men after the menopause.
Genetics: A family history of gout increases the likelihood of the condition developing.
Lifestyle choices: Alcohol consumption interferes with the removal of uric acid from the body. Eating a
high-purine diet also increases the amount of uric acid in the body.
Lead exposure: Chronic lead exposure has been linked to some cases of gout.
Medications: Certain medications can increase the levels of uric acid in the body; these include some
diuretics and drugs containing salicylate.
Weight: Being overweight increases the risk of gout as there is more turnover of body tissue, which
means more production of uric acid as a metabolic waste product. Higher levels of body fat also increase
levels of systemic inflammation as fat cells produce pro-inflammatory cytokines.
Recent trauma or surgery: Increases risk.
Other health problems: Renal insufficiency and other kidney problems can reduce the body’s ability to
efficiently remove waste products, leading to elevated uric acid levels. Other conditions associated with
gout include high blood pressure and diabetes.
Complications
In some cases, gout can develop into more serious conditions, such as:
Kidney stones: If urate crystals collect in the urinary tract, they can become kidney stones.
Recurrent gout: Some people only ever have one flare up; others may have regular recurrences,
causing gradual damage to the joints and surrounding tissue.
Diagnosis
Tests to help diagnose gout may include:
4. Joint fluid test: Use a needle to draw fluid from affected joint. Urate crystals may be visible when the
fluid is examined under a microscope.
Blood test: Doctor may recommend a blood test to measure the levels of uric acid and creatinine in
blood. Blood test results can be misleading, though. Some people have high uric acid levels, but never
experience gout. And some people have signs and symptoms of gout, but don't have unusual levels of
uric acid in their blood.
X-ray imaging: Joint X-rays can be helpful to rule out other causes of joint inflammation.
Ultrasound. Musculoskeletal ultrasound can detect urate crystals in a joint or in a tophus. This technique
is more widely used in Europe than in the United States.
Dual energy CT scan: This type of imaging can detect the presence of urate crystals in a joint, even when
it is not acutely inflamed. This test is not used routinely in clinical practice due to the expense and is not
widely available.
Treatment
1. Medications to treat gout attacks
Nonsteroidal anti-inflammatory drugs (NSAIDs). NSAIDs include over-the-counter options such
as ibuprofen (Advil, Motrin IB, others) and naproxen sodium (Aleve), as well as more-powerful
prescription NSAIDs such as indomethacin (Indocin) or celecoxib (Celebrex).
Colchicine, a type of pain reliever that effectively reduces gout pain.
Corticosteroids. Corticosteroid medications, such as the drug prednisone, may control gout
inflammation and pain.
2. Medications to prevent gout complications
Medications that block uric acid production. Drugs called xanthine oxidase inhibitors (XOIs),
including allopurinol (Aloprim, Lopurin, Zyloprim) and febuxostat (Uloric), limit the amount of
uric acid
Medication that improves uric acid removal. These drugs, called uricosurics, include
probenecid (Probalan) and lesinurad (Zurampic).